Abstract

The rate of infection complications is rare and varies from 0,4 to 6%. However, there is no unique protocol of treatment of mediastinitis in case of pediatric population. We assessed our results in 2 neonates, who have been treated with VAC therapy. These preliminary results show that VAC therapy is a promising alternative to the current treatment options available to neonates.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.